Evidence map›Paper›PMID 42870976›Full record

ArticleFrontiers in allergy2026

Could

José Alberto Montoya-Alonso, Alfonso Balmori-de la Puente, Iván Rodríguez-Escolar, Manuel Collado-Cuadrado, Alberto Gil-Abad, Elena Carretón, Rodrigo Morchón

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

José Alberto Montoya-AlonsoResearch Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Alfonso Balmori-de la PuenteZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, Salamanca, Spain.
Iván Rodríguez-EscolarZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, Salamanca, Spain.
Manuel Collado-CuadradoZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, Salamanca, Spain.
Alberto Gil-AbadZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, Salamanca, Spain.
Elena CarretónResearch Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
Rodrigo MorchónZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, Salamanca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Although human infection with Methods: A total of 125 anonymized serum samples from patients diagnosed with allergic conditions were analyzed. Specific Immunoglobulin (Ig) G antibodies against Results: Anti-D. immitis IgE positivity was detected in 23.2% of patients, while 6.4% showed simultaneous IgG positivity against Discussion: These findings suggest that exposure to

Indexed as

allergic sensitizationDirofilaria immitiseosinophiliahuman dirofilariosisIgEOne Health

Identifiers

PMID42870976
PMCPMC13658081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.